233 related articles for article (PubMed ID: 22176646)
21. Recent and ongoing clinical trials in glioblastoma.
Lombardi G
Clin Adv Hematol Oncol; 2018 Jul; 16(7):480-483. PubMed ID: 30067618
[No Abstract] [Full Text] [Related]
22. Glioblastoma multiforme: a review of where we have been and where we are going.
Adamson C; Kanu OO; Mehta AI; Di C; Lin N; Mattox AK; Bigner DD
Expert Opin Investig Drugs; 2009 Aug; 18(8):1061-83. PubMed ID: 19555299
[TBL] [Abstract][Full Text] [Related]
23. Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology.
ElBanan MG; Amer AM; Zinn PO; Colen RR
Neuroimaging Clin N Am; 2015 Feb; 25(1):141-53. PubMed ID: 25476518
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of multifocal and multicentric glioblastoma.
Li Y; Zhang ZX; Huang GH; Xiang Y; Yang L; Pei YC; Yang W; Lv SQ
J Clin Neurosci; 2021 Jan; 83():71-76. PubMed ID: 33358091
[TBL] [Abstract][Full Text] [Related]
26. Emerging circulating biomarkers in glioblastoma: promises and challenges.
Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
[TBL] [Abstract][Full Text] [Related]
27. A novel treatment for glioblastoma: integrin inhibition.
Chamberlain MC; Cloughsey T; Reardon DA; Wen PY
Expert Rev Neurother; 2012 Apr; 12(4):421-35. PubMed ID: 22449214
[TBL] [Abstract][Full Text] [Related]
28. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma.
Zhang N; Wei L; Ye M; Kang C; You H
Front Immunol; 2020; 11():592612. PubMed ID: 33329578
[TBL] [Abstract][Full Text] [Related]
29. Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China.
Ma X; Lv Y; Liu J; Wang D; Huang Q; Wang X; Li G; Xu S; Li X
J Clin Neurosci; 2009 Dec; 16(12):1595-8. PubMed ID: 19793663
[TBL] [Abstract][Full Text] [Related]
30. Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.
Cela I; Capone E; Trevisi G; Sala G
Semin Cancer Biol; 2024 Jun; 101():25-43. PubMed ID: 38754752
[TBL] [Abstract][Full Text] [Related]
31. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
Gatto L; Franceschi E; Di Nunno V; Tosoni A; Lodi R; Brandes AA
Oncologist; 2021 Oct; 26(10):865-878. PubMed ID: 34105205
[TBL] [Abstract][Full Text] [Related]
32. Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.
Chaudhry NS; Shah AH; Ferraro N; Snelling BM; Bregy A; Madhavan K; Komotar RJ
Cancer Invest; 2013 Jun; 31(5):287-308. PubMed ID: 23614654
[TBL] [Abstract][Full Text] [Related]
33. Hierarchical non-negative matrix factorization (hNMF): a tissue pattern differentiation method for glioblastoma multiforme diagnosis using MRSI.
Li Y; Sima DM; Cauter SV; Croitor Sava AR; Himmelreich U; Pi Y; Van Huffel S
NMR Biomed; 2013 Mar; 26(3):307-19. PubMed ID: 22972709
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Reardon DA; Wen PY
Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
[TBL] [Abstract][Full Text] [Related]
35. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
Jarzabek MA; Sweeney KJ; Evans RL; Jacobs AH; Stupp R; O'Brien D; Berger MS; Prehn JH; Byrne AT
Drug Discov Today; 2013 Nov; 18(21-22):1052-66. PubMed ID: 23792334
[TBL] [Abstract][Full Text] [Related]
36. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
37. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
Gilbert MR
Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
[TBL] [Abstract][Full Text] [Related]
38. Imaging Genomics in Glioblastoma Multiforme: A Predictive Tool for Patients Prognosis, Survival, and Outcome.
Anil R; Colen RR
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):731-740. PubMed ID: 27742113
[TBL] [Abstract][Full Text] [Related]
39. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
Nicholas MK; Lukas RV; Chmura S; Yamini B; Lesniak M; Pytel P
Semin Oncol; 2011 Apr; 38(2):243-53. PubMed ID: 21421114
[TBL] [Abstract][Full Text] [Related]
40. Recurrent glioblastoma multiforme: a review of natural history and management options.
Hou LC; Veeravagu A; Hsu AR; Tse VC
Neurosurg Focus; 2006 Apr; 20(4):E5. PubMed ID: 16709036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
